Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cancer Genetics Inc (CGIX)

Cancer Genetics Inc (CGIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,432
  • Shares Outstanding, K 4,075
  • Annual Sales, $ 7,310 K
  • Annual Income, $ -6,710 K
  • 60-Month Beta 2.78
  • Price/Sales 1.37
  • Price/Cash Flow 22.27
  • Price/Book 1.34
Trade CGIX with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.16 +18.52%
on 11/10/20
2.69 -4.83%
on 12/01/20
+0.33 (+14.80%)
since 11/04/20
3-Month
2.11 +21.47%
on 10/30/20
5.26 -51.33%
on 09/09/20
-1.77 (-40.88%)
since 09/04/20
52-Week
1.92 +33.33%
on 03/19/20
10.39 -75.36%
on 08/24/20
-5.14 (-66.75%)
since 12/04/19

Most Recent Stories

More News
Prostate Cancer Diagnostics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027

The research report on Prostate Cancer Diagnostics provide insights on growth-influencing factors such as industry trends, understanding consumer demands, product application, competitive landscape, pricing...

DXD.VN : 0.040 (unch)
A : 115.15 (+1.38%)
BIOC : 5.03 (-1.76%)
CGIX : 2.56 (+4.07%)
FMI : 136.95 (-0.04%)
GHDX : 63.44 (-0.69%)
OPK : 4.76 (+3.03%)
SIEGY : 68.5800 (+1.30%)
Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm - MVC, PTI, CGIX, STND

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

MVC : 8.83 (+1.61%)
PTI : 1.0200 (-0.97%)
CGIX : 2.56 (+4.07%)
STND : 32.90 (+0.15%)
WeissLaw LLP Reminds CGIX, ALSK, EIGI, and HDS Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

CGIX : 2.56 (+4.07%)
ALSK : 3.76 (+23.28%)
EIGI : 9.45 (+0.11%)
HDS : 55.83 (-0.18%)
Halper Sadeh LLP Announces it is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm - PNM, STND, CBMG, CGIX

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

PNM : 49.24 (+0.14%)
STND : 32.90 (+0.15%)
CBMG : 18.69 (+0.97%)
CGIX : 2.56 (+4.07%)
Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm

, /PRNewswire/ -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown , is investigating potential claims concerning whether the following proposed mergers are fair...

TGC : 1.1900 (+2.59%)
AKER : 2.04 (+0.99%)
CGIX : 2.56 (+4.07%)
DNKN : 106.34 (-0.05%)
SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Investigations; Investors are Encouraged to Contact the Firm - CBMG, MVC, PTI, CGIX

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

CBMG : 18.69 (+0.97%)
MVC : 8.83 (+1.61%)
PTI : 1.0200 (-0.97%)
CGIX : 2.56 (+4.07%)
SHAREHOLDER ALERT: WeissLaw LLP Investigates Cancer Genetics, Inc.

, /PRNewswire/ --  is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Cancer Genetics, Inc. ("CGIX" or the "Company") (NASDAQ: CGIX) in connection...

CGIX : 2.56 (+4.07%)
Cancer Genetics Reports Third Quarter 2020 Financial Results

Cancer Genetics, Inc. (the "Company") (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, announced today financial and operating results for the quarter ended...

CGIX : 2.56 (+4.07%)
Moore Kuehn Encourages CGIX, CXO, CBMG, and RESI Investors to Contact Law Firm

Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders....

RESI : 16.33 (-0.18%)
CGIX : 2.56 (+4.07%)
CBMG : 18.69 (+0.97%)
CXO : 64.44 (+7.36%)
Large Study Shows That A Simple Blood Test Can Accurately Differentiate Between Benign and Malignant Lesions

LONDON, Nov. 9, 2020 /PRNewswire/ -- A large, landmark study published in the American Cancer Society's prestigious journal 'Cancer Cytopathology' shows that a simple non-invasive blood test (liquid biopsy)...

CGIX : 2.56 (+4.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Cancer Genetics, Inc. operates as a diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer. The company's tests target cancers, including hematological, urogenital, and HPV-associated...

See More

Key Turning Points

2nd Resistance Point 2.69
1st Resistance Point 2.63
Last Price 2.56
1st Support Level 2.46
2nd Support Level 2.35

See More

52-Week High 10.39
Fibonacci 61.8% 7.15
Fibonacci 50% 6.16
Fibonacci 38.2% 5.16
Last Price 2.56
52-Week Low 1.92

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar